Researchers identify a treatment for a rare bone loss disorder that might also lead to help for aging brittle bones
A possible ‘first-line’ treatment for a rare bone loss disease has been identified by a research team led by Tohoku University in Japan. The research findings, published in the journal Molecular Cell, could also provide insight into treating age-related osteoporosis.
Hajdu-Cheney syndrome is a rare genetic disease that leads to severe osteoporosis and developmental defects, including the reabsorption of bones in the hands and feet. The disease is associated with mutations in a particular gene, called NOTCH2, which codes for proteins involved with bone maintenance. The NOTCH2 proteins usually help balance destruction and construction essential for bone maintenance and repair. Mutations associated with Hajdu-Cheney syndrome upset that balance, but the exact mechanisms causing bone resorption have not been well understood.
Now, through a series of detailed tests, molecular biologist Hiroyuki Inuzuka and his colleagues have worked out the specific molecular pathway that results in Hajdu-Cheney syndrome.
They found that this particular NOTCH2 mutation does not maintain normal NOTCH2 protein abundance, with the help of another protein, called FBW7. To discover this, the researchers knocked out the gene for Fbw7 in the bones of mice. Without the gene and resulting protein, the mice had severe osteoporosis, much like people with Hajdu-Cheney syndrome — indicating that FBW7 is the primary regulator of this system.
They further determined that in humans with Hajdu-Cheney syndrome, the FBW7 protein was unable to bind to NOTCH2 proteins because the binding spot is missing in osteoclasts. This mutation allows the osteoclasts to over-operate, breaking down too much bone tissue.
The researchers were able to reverse bone loss in the knock-out mice with the elevated NOTCH2 by giving them a medication that blocks osteoclast formation. They tried several different treatments, including a chemical compound called DAPT that was particularly effective. DAPT has been shown to help with osteoarthritis by inhibiting function of NOTCH proteins in other studies. Using DAPT as well as Zoledronic acid, a common medication for osteoporosis, “may become a first-line treatment for Hadju-Cheney syndrome,” the researchers conclude in their study.
“By clearly identifying the relationship between FBW7 and NOTCH2 proteins, we have identified potential therapeutic targets for patients with rare bone diseases as well as much more widespread age-related osteoporosis,” said Inuzuka.
Learn more: Reversing severe bone loss
The Latest on: Bone loss
via Google News
The Latest on: Bone loss
- Weight-loss surgery in adolescents can weaken bones, says studyon November 27, 2020 at 7:34 am
... a significant increase in bone marrow fat and a decrease in bone density in the lumbar spine. Read| A bariatric surgeon’s guide to understanding obesity Dr Bredella said the loss of bone density ...
- Common Weight-Loss Surgery Can Weaken a Teen's Boneson November 24, 2020 at 7:01 am
Sleeve gastrectomy, a procedure used to help obese people lose weight, may damage the bones of teen patients, a new study finds. "Childhood obesity is a major public health issue that has increased ...
- Popular weight-loss surgery in teenagers weakens boneson November 23, 2020 at 4:00 pm
A common weight loss surgery for adolescents with obesity called sleeve gastrectomy has harmful effects on bones, according to a new study.
- Ultrasound Bone Sonometers Market Research Study including Growth Factors, Types and Application by regions from 2020 to 2025on November 19, 2020 at 1:49 am
The global Ultrasound Bone Sonometers market report provides geographic analysis covering regions, such as North ...
- Are Doctors Doing Enough to Manage Bone Risks for People With Asthma Who Take Steroids?on November 18, 2020 at 2:11 pm
New data shows that the risk of osteoporosis and fractures is heightened in people with asthma who take both oral and inhaled steroid medications.
- Study Finds Osteoporosis Is Underdiagnosed and Undertreated in Menon November 12, 2020 at 7:44 pm
and diseases or conditions associated with bone loss, according to the International Society for Clinical Densitometry. “Osteoporosis is a silent disease, and people often don’t seek help ...
- Prevention of Bone Loss and Management of Fracture Risk in HIV-infected Individualson November 12, 2020 at 4:00 pm
Prevention of bone loss is likely to become an important component of HIV care as the HIV-infected patient population grows older. In this article, we present an overview of the literature on bone ...
- Bone Densitometer Market Share Forecast to Witness Considerable Growth from 2020 to 2030 - Hologic, DMS Imaging, Medonica Co LTDon November 12, 2020 at 4:00 pm
Physicians generally look for the lower lumbar, hips and spine for evaluating and determining the bone loss. This process is mostly carried out to diagnose osteoporosis, for evaluating the patient ...
- Cancer-Treatment-Induced Bone Loss, Part 1on November 11, 2020 at 4:00 pm
Purpose: The pathophysiology, frequency, sequelae, diagnosis, and treatment of cancer-treatment-induced bone loss (CTIBL) are discussed. Summary: CTIBL is a long-term complication associated with ...
via Bing News